Skip to content
BLACK BOOK
manufacturer✓ Verified

Mereo BioPharma Group plc

Pharmaceutical Preparations · London

  1. PrincipalsChristine Ann FoxChief Financial OfficerDenise Scots-KnightChief Executive OfficerJohn A. LewickiChief Scientific Officerand 10 more
  2. CompanyMereo BioPharma Group plcLondon
Request a quote

Mereo BioPharma Group plc is an SEC-registered Nasdaq-listed company (ticker MREO) classified under SIC 2834: Pharmaceutical Preparations.

Capabilities

✓ Pharmaceutical manufacturing
Evidence for each capability
  • Pharmaceutical manufacturing. SIC 2834 — Pharmaceutical Preparations — SEC EDGAR company submissions

People 13

Chief executive

Denise Scots-KnightChief Executive Officer

Chair & board

Anders EkblomDirector (Board)
Annalisa JenkinsDirector (Board)
Daniel ShamesDirector (Board)
Deepika PakianathanDirector (Board)

Finance

Christine Ann FoxChief Financial Officer

Legal

Charles SermonGeneral Counsel
Everyone else on file (2)
John A. LewickiChief Scientific Officer
Alexandra Hughes-WilsonOfficer (see SEC filing)

Supplier profile

Production
Yes

Source timeline

  1. Record created from SEC EDGAR company submissions

    SEC EDGAR company submissions ↗
  2. Christine Ann Fox — Chief Financial Officer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  3. Denise Scots-Knight — Chief Executive Officer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  4. John A. Lewicki — Chief Scientific Officer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗

Similar makers